Home Coronavirus

Thai Hospitals, Oxford Launch 1st Comparative study of Covid-19 Treatments

Covid-19 Coronavirus Theraputics Drugs Merck Pfizer Drugs

Mahidol University and the University of Oxford announced the launch of the world’s first comparative study for Covid-19 drugs.

The Faculty of Tropical Medicine of Mahidol University and the Mahidol-Oxford Tropical Medicine Research Unit held a press conference to announce the start of the research project on Covid-19 drugs involving many international institutions.

The project was aimed at finding medications to treat Covid-19 and evaluating their effectiveness.

The study involves three Thai hospitals – Hospital for Tropical Diseases, Vajira Hospital and Bangplee Hospital.

Weerapong Phumratanaprapin, dean of the Faculty of Tropical Medicine at Mahidol University, said health and government officials needed clear information to support treatment.

Currently, a few medications could reduce the virus directly and the announced study would cover two oral medications – favipiravir and ivermectin – and two parenteral medications – remdesivir and Regeneron – he said.

The research project will need 750 volunteers worldwide and the Thai hospitals will recruit about 200 volunteers.